KCE, L., WH, M., W, C., CSF, W., & SKP, C. (2019). Outcomes of neoadjuvant chemotherapy using gemcitabine and cisplatin in muscle invasive bladder cancer: A retrospective analysis of the patient and treatment factors in a single institute. Cancer reports (Hoboken, N.J.), 2(4), e1170. https://doi.org/10.1002/cnr2.1170
Chicago Style (17th ed.) CitationKCE, Lee, Mui WH, Chan W, Wong CSF, and Chu SKP. "Outcomes of Neoadjuvant Chemotherapy Using Gemcitabine and Cisplatin in Muscle Invasive Bladder Cancer: A Retrospective Analysis of the Patient and Treatment Factors in a Single Institute." Cancer Reports (Hoboken, N.J.) 2, no. 4 (2019): e1170. https://doi.org/10.1002/cnr2.1170.
MLA (9th ed.) CitationKCE, Lee, et al. "Outcomes of Neoadjuvant Chemotherapy Using Gemcitabine and Cisplatin in Muscle Invasive Bladder Cancer: A Retrospective Analysis of the Patient and Treatment Factors in a Single Institute." Cancer Reports (Hoboken, N.J.), vol. 2, no. 4, 2019, p. e1170, https://doi.org/10.1002/cnr2.1170.